Literature DB >> 8286638

Persistent infection with Ehrlichia chaffeensis.

J S Dumler1, W L Sutker, D H Walker.   

Abstract

Although persistent infection of animals by members of the genus Ehrlichia is well known and may be associated with subsequent severe or fatal illness, persistent infection of humans with Ehrlichia chaffeensis has not been reported. Herein we report a typical case of serologically documented acute ehrlichiosis; despite therapy with tetracycline and chloramphenicol, the patient's condition progressively worsened and he suffered multiple secondary infections and gastrointestinal hemorrhage. He died 68 days after his initial hospitalization. Retrospective immunohistologic examination of both acute-phase bone marrow specimens (obtained day 12 of illness) and postmortem liver tissue specimens (obtained day 68 after onset of disease) revealed E. chaffeensis morulae in mononuclear cells, presumably macrophages and monocytes. Findings of this case provide the first definitive evidence that E. chaffeensis is capable of establishing persistent human infection and suggest a role for this obligate intracellular bacterium in the induction of immune compromise associated with a fatal outcome.

Entities:  

Mesh:

Year:  1993        PMID: 8286638     DOI: 10.1093/clinids/17.5.903

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  48 in total

1.  Ehrlichia chaffeensis expresses macrophage- and tick cell-specific 28-kilodalton outer membrane proteins.

Authors:  Vijayakrishna Singu; Haijie Liu; Chuanmin Cheng; Roman R Ganta
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  William Levin Sutker, MD: a conversation with the editor.

Authors:  William Levin Sutker; William Clifford Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-04

3.  Early induction of interleukin-10 limits antigen-specific CD4⁺ T cell expansion, function, and secondary recall responses during persistent phagosomal infection.

Authors:  Abinav Kumar Singh; Nagaraja R Thirumalapura
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

4.  A human case of monocytic ehrlichiosis with adult respiratory distress syndrome in northern California.

Authors:  D J Vugia; E Holmberg; E M Steffe; M S Ascher; D Gallo
Journal:  West J Med       Date:  1996-06

5.  Delayed clearance of Ehrlichia chaffeensis infection in CD4+ T-cell knockout mice.

Authors:  Roman R Ganta; Chuanmin Cheng; Melinda J Wilkerson; Stephen K Chapes
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

6.  Attenuated Mutants of Ehrlichia chaffeensis Induce Protection against Wild-Type Infection Challenge in the Reservoir Host and in an Incidental Host.

Authors:  Arathy D S Nair; Chuanmin Cheng; Deborah C Jaworski; Suhasini Ganta; Michael W Sanderson; Roman R Ganta
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

7.  Histologic, serologic, and molecular analysis of persistent ehrlichiosis in a murine model.

Authors:  Juan P Olano; Gary Wen; Hui-Min Feng; Jere W McBride; David H Walker
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Immunodiagnosis of human granulocytic ehrlichiosis by using culture-derived human isolates.

Authors:  M D Ravyn; J L Goodman; C B Kodner; D K Westad; L A Coleman; S M Engstrom; C M Nelson; R C Johnson
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Cytopathic effect, plaque formation, and lysis of Ehrlichia chaffeensis grown on continuous cell lines.

Authors:  P Brouqui; M L Birg; D Raoult
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

10.  Protective heterologous immunity against fatal ehrlichiosis and lack of protection following homologous challenge.

Authors:  Nagaraja R Thirumalapura; Heather L Stevenson; David H Walker; Nahed Ismail
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.